Literature DB >> 23303460

Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma.

Gerald Saldanha, Linda Potter, Priya Shendge, Joy Osborne, Steve Nicholson, NgiWieh Yii, Sanjay Varma, Muhammad Imran Aslam, Shona Elshaw, Eftychios Papadogeorgakis, J Howard Pringle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23303460     DOI： 10.1038/jid.2012.477

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  14 in total

1.  Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma.

Authors:  Nicholas Latchana; Mallory J DiVincenzo; Kelly Regan; Zachary Abrams; Xiaoli Zhang; Naduparambil K Jacob; Alejandro A Gru; Paolo Fadda; Joseph Markowitz; J Harrison Howard; William E Carson
Journal:  J Surg Oncol       Date:  2018-08-21       Impact factor: 3.454

Review 2.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

Review 3.  Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives.

Authors:  Hisashi Kanemaru; Yukari Mizukami; Akira Kaneko; Ikko Kajihara; Satoshi Fukushima
Journal:  Curr Treat Options Oncol       Date:  2022-03-17

4.  microRNA-10b is a prognostic biomarker for melanoma.

Authors:  Gerald Saldanha; Shona Elshaw; Parysatis Sachs; Hisham Alharbi; Prashant Shah; Ann Jothi; J Howard Pringle
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

Review 5.  Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.

Authors:  Sharon K Huang; Dave S B Hoon
Journal:  Mol Oncol       Date:  2015-12-17       Impact factor: 6.603

6.  Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.

Authors:  Shanthi Sabarimurugan; Madhav Madurantakam Royam; Ankita Das; Shrestha Das; Gothandam K M; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

Review 7.  Emerging Biomarkers in Cutaneous Melanoma.

Authors:  Anna Eisenstein; Estela Chen Gonzalez; Rekha Raghunathan; Xixi Xu; Muzhou Wu; Emily O McLean; Jean McGee; Byungwoo Ryu; Rhoda M Alani
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

Review 8.  MiR-21: an environmental driver of malignant melanoma?

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2015-06-27       Impact factor: 5.531

9.  Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?

Authors:  Christiane Margue; Susanne Reinsbach; Demetra Philippidou; Nicolas Beaume; Casandra Walters; Jochen G Schneider; Dorothée Nashan; Iris Behrmann; Stephanie Kreis
Journal:  Oncotarget       Date:  2015-05-20

10.  Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients.

Authors:  Iris Behrmann; Christiane Margue; Stephanie Kreis
Journal:  EBioMedicine       Date:  2015-07-13       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.